Fighting Melanoma,
Flip-dose ipilimumab and nivolumab after resection of mucosal melanoma is associated with outcomes improved over that of…
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma
Overview of attention for article published in Clinical Cancer Research, March 2023
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (74th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 19 Mendeley